RecruitingNCT07389473
Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
An Observational Study to Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device
Sponsor
Gaize
Enrollment
50 participants
Start Date
Apr 17, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria3
- Adults aged between 18 and 65, having given written informed consent to participate in the research trial.
- Currently using a psychiatric medication as prescribed by a healthcare professional for longer than 3 months.
- Normal or corrected to normal vision using either glasses or contact lenses, or surgery.
Exclusion Criteria10
- Enrolled in, or participated in another clinical trial within 30 days before the study
- Having a prosthetic eye, missing eye, or wearer of an eye patch LASIK or other eye surgery within the prior 21 days.
- Had your eyes dilated by a medical doctor in the previous 24 hours.
- Photosensitive epilepsy
- Diagnosed with clinical blindness
- Medical Conditions: Participants with medical conditions or medications that could significantly affect cognitive and motor functions are excluded. Participants with conditions such as Glaucoma, macular degeneration, cataracts, lazy eye (amblyopia), or optic neuritis, or genetic anisocoria (unequal pupil size) will be excluded.
- Current or past head inject/ traumatic brain injury (TBI)
- Pregnancy: Pregnant individuals will be excluded from the study due to the potential risks associated with psychiatric medications.
- History of Severe Motion Sickness: Participants with a history of severe motion sickness in VR environments may be excluded, as they may not tolerate the VR headset well.
- Potential participants who are unable to provide consent for the study.
Interventions
DRUGPrescription Psychotropic Medications
Currently using a psychiatric medication as prescribed by a healthcare professional for longer than 3 months.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07389473
Related Trials
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
NCT0679339767 locations
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
NCT003971111 location
Prevalence and Severity of Depression Among Cardiothoracic Surgery Healthcare Workers in Baghdad: A PHQ-9 Cross-Sectional Study
NCT067027611 location
Neurostimulation Versus Therapy for Problems With Emotions
NCT057120571 location
Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers
NCT000246351 location